I. David Schwartz

1.3k total citations
28 papers, 896 citations indexed

About

I. David Schwartz is a scholar working on Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, I. David Schwartz has authored 28 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Genetics. Recurrent topics in I. David Schwartz's work include Growth Hormone and Insulin-like Growth Factors (12 papers), Birth, Development, and Health (4 papers) and Thyroid Disorders and Treatments (4 papers). I. David Schwartz is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (12 papers), Birth, Development, and Health (4 papers) and Thyroid Disorders and Treatments (4 papers). I. David Schwartz collaborates with scholars based in United States, Puerto Rico and Czechia. I. David Schwartz's co-authors include Diana B. Petitti, Giuseppina Imperatore, Catherine Pihoker, Beatriz L. Rodríguez, Georgeanna J. Klingensmith, Allen W. Root, Barry B. Bercu, Dana Dabelea, Lawrence M. Dolan and Arleta Rewers and has published in prestigious journals such as Nature Communications, The Journal of Clinical Endocrinology & Metabolism and PEDIATRICS.

In The Last Decade

I. David Schwartz

28 papers receiving 863 citations

Peers

I. David Schwartz
I. David Schwartz
Citations per year, relative to I. David Schwartz I. David Schwartz (= 1×) peers Chunxiu Gong

Countries citing papers authored by I. David Schwartz

Since Specialization
Citations

This map shows the geographic impact of I. David Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. David Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. David Schwartz more than expected).

Fields of papers citing papers by I. David Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. David Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. David Schwartz. The network helps show where I. David Schwartz may publish in the future.

Co-authorship network of co-authors of I. David Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of I. David Schwartz. A scholar is included among the top collaborators of I. David Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. David Schwartz. I. David Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klammt, Jürgen, David Neumann, Evelien Gevers, et al.. (2018). Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation. Nature Communications. 9(1). 2105–2105. 79 indexed citations
2.
Peng, Fang, I. David Schwartz, Michael A. Derr, et al.. (2009). Familial Short Stature Caused by Haploinsufficiency of the Insulin-Like Growth Factor I Receptor due to Nonsense-Mediated Messenger Ribonucleic Acid Decay. The Journal of Clinical Endocrinology & Metabolism. 94(5). 1740–1747. 54 indexed citations
3.
Paris, Carolyn A., Giuseppina Imperatore, Georgeanna J. Klingensmith, et al.. (2009). Predictors of Insulin Regimens and Impact on Outcomes in Youth with Type 1 Diabetes: The SEARCH for Diabetes in Youth Study. The Journal of Pediatrics. 155(2). 183–189.e1. 128 indexed citations
4.
Peng, Fang, I. David Schwartz, Michael A. Derr, et al.. (2009). Familial Short Stature Caused by Haploinsufficiency of The Insulin-like Growth Factor 1 Receptor Due to Nonsense-Mediated mRNA Decay. Molecular Endocrinology. 23(4). 585–585. 3 indexed citations
5.
Mauras, Nelly, Paul Desrosiers, Robert Rapaport, et al.. (2008). Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated With Growth Hormone: A Randomized, Placebo-Controlled, Multicenter Trial for One to Three Years. Obstetrical & Gynecological Survey. 63(7). 438–440. 4 indexed citations
6.
Mauras, Nelly, Paul Desrosiers, Robert Rapaport, et al.. (2007). Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated with Growth Hormone: A Randomized, Placebo-Controlled, Multicenter Trial for One to Three Years. The Journal of Clinical Endocrinology & Metabolism. 93(3). 823–831. 99 indexed citations
7.
Belmont, John W., Barbara S. Reid, William R. Taylor, et al.. (2002). Congenital sucrase-isomaltase deficiency presenting with failure to thrive, hypercalcemia, and nephrocalcinosis. BMC Pediatrics. 2(1). 4–4. 24 indexed citations
8.
Schwartz, I. David. (2000). Failure To Thrive: An Old Nemesis in the New Millennium. Pediatrics in Review. 21(8). 257–264. 31 indexed citations
9.
Schwartz, I. David, et al.. (2000). Growth During and After a Trial of Growth Hormone Releasing Hormone 1-29 in Children with Idiopathic Short Stature or Growth Hormone Neurosecretory Dysfunction. Journal of Pediatric Endocrinology and Metabolism. 13(6). 645–50. 1 indexed citations
10.
Schwartz, I. David. (2000). Failure To Thrive: An Old Nemesis in the New Millennium. Pediatrics in Review. 21(8). 257–264. 8 indexed citations
11.
Alon, Uri S., Wayne D. Moore, & I. David Schwartz. (1999). Effect of Acid-Phosphate Vs Neutral-Phosphate on Urine Acidity, Acid-Base Balance and Mineral Homeostasis in Children with Familial Hypophosphatemic Rickets (XLH). Pediatric Research. 45(4, Part 2 of 2). 328A–328A. 1 indexed citations
12.
Schwartz, I. David & J Grunt. (1997). Growth, short stature, and the use of growth hormone: Considerations for the practicing pediatrician—An update. Current Problems in Pediatrics. 27(1). 1–40. 1 indexed citations
13.
Schwartz, I. David & Daniel Scagliotti. (1995). Verapamil-induced ?primary? polydipsia. Pediatric Cardiology. 16(5). 228–230. 1 indexed citations
14.
Schwartz, I. David. (1994). Serum Concentrations of Alpha-fetoprotein in Children With Primary Hypothyroidism. Archives of Pediatrics and Adolescent Medicine. 148(2). 225–225. 2 indexed citations
15.
Schwartz, I. David, et al.. (1994). Prolactinoma Associated with Transient Growth Hormone Deficiency but Persistent Growth Retardation. Journal of Pediatric Endocrinology and Metabolism. 7(1). 69–73. 3 indexed citations
16.
Grunt, J & I. David Schwartz. (1992). Growth, short stature, and the use of growth hormone: considerations for the practicing pediatrician. Current Problems in Pediatrics. 22(9). 390–412. 3 indexed citations
17.
Schwartz, I. David & Barry B. Bercu. (1992). Dextrothyroxine in the Treatment of Generalized Thyroid Hormone Resistance in a Boy Homozygous for a Defect in the T 3 Receptor. Thyroid. 2(1). 15–19. 20 indexed citations
18.
Schwartz, I. David, et al.. (1991). Homozygosity for a Dominant Negative Thyroid Hormone Receptor Gene Responsible for Generalized Resistance to Thyroid Hormone*. The Journal of Clinical Endocrinology & Metabolism. 73(5). 990–994. 93 indexed citations
19.
Schwartz, I. David, et al.. (1990). Endocrinopathies in Cornelia de Lange syndrome. The Journal of Pediatrics. 117(6). 920–923. 8 indexed citations
20.
Schwartz, I. David. (1990). Linear Growth Response to Exogenous Growth Hormone in Children With Short Stature. Archives of Pediatrics and Adolescent Medicine. 144(10). 1092–1092. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026